Neuropeptide Y 13-36 (porcine)
Cat. No. 1177
Alternative Name: NPY 13-36 (porcine)
Biological ActivityNeuropeptide Y2 receptor agonist.
(Modifications: Tyr-24 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Aguirre et al (1990) Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci.Lett. 118 5. PMID: 2259468.
Martire et al (1993) Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type. Eur.J.Pharmacol. 230 231. PMID: 8422905.
Aguirre et al (1995) Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius. Brain Res. 684 159. PMID: 7583217.
If you know of a relevant citation for this product please let us know.
Keywords: Neuropeptide Y 13-36 (porcine), supplier, Y2, receptor, agonists, Neuropeptides, Y, Receptors, NPY, NeuropeptideY, (porcine), 13-36, NPY1336
Find multiple products by catalog number
New Products in this Area
Endogenous ligand for canine kisspeptin receptorMK 0677
High affinity ghrelin receptor agonistUrantide
Selective and competitive urotensin II antagonistML 154
Potent neuropeptide S receptor (NPSR) antagonistTC OT 39
Potent non-peptide oxytocin receptor partial agonist; also V1a receptor antagonistTolvaptan
Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally active
One Day Symposium
March 17, 2015